Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method
Authors
Keywords
-
Journal
SCHIZOPHRENIA BULLETIN
Volume 40, Issue 2, Pages 314-326
Publisher
Oxford University Press (OUP)
Online
2014-02-04
DOI
10.1093/schbul/sbu001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia
- (2013) Loukia M. Spineli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Equipercentile linking of the BPRS and the PANSS
- (2013) S. Leucht et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study
- (2013) Henry A. Nasrallah et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Efficacy and safety of lurasidone 80mg/day and 160mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial
- (2013) Antony Loebel et al. SCHIZOPHRENIA RESEARCH
- How to compare doses of different antipsychotics: A systematic review of methods
- (2013) Maxine X. Patel et al. SCHIZOPHRENIA RESEARCH
- A double-blind, randomized, placebo-controlled study with JNJ-37822681, a novel, highly selective, fast dissociating D2 receptor antagonist in the treatment of acute exacerbation of schizophrenia
- (2012) Mark E. Schmidt et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it?
- (2012) Larry Alphs et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Exploratory Analyses of Efficacy Data From Schizophrenia Trials in Support of New Drug Applications Submitted to the US Food and Drug Administration
- (2012) Ni A. Khin et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
- (2012) Masaaki Ogasa et al. PSYCHOPHARMACOLOGY
- Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study
- (2011) Herbert Y. Meltzer et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia
- (2011) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- International Consensus Study of Antipsychotic Dosing
- (2010) David M. Gardner et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Randomized, Double-Blind, Placebo-Controlled Study of 2 Dose Ranges of Paliperidone Extended-Release in the Treatment of Subjects With Schizoaffective Disorder
- (2010) Carla M. Canuso et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia
- (2010) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Randomized, Double-Blind, Placebo-Controlled Study of Paliperidone Extended-Release and Quetiapine in Inpatients With Recently Exacerbated Schizophrenia
- (2009) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different Drugs
- (2009) Nancy C. Andreasen et al. BIOLOGICAL PSYCHIATRY
- The Efficacy and Safety of Blonanserin Compared with Haloperidol in Acute-Phase Schizophrenia
- (2009) Esther Garcia et al. CNS DRUGS
- Lurasidone in the Treatment of Acute Schizophrenia
- (2009) Mitsutaka Nakamura et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
- (2008) Stefan Leucht et al. AMERICAN JOURNAL OF PSYCHIATRY
- Four-Week, Double-Blind, Placebo- and Ziprasidone-Controlled Trial of Iloperidone in Patients With Acute Exacerbations of Schizophrenia
- (2008) Andrew J. Cutler et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Efficacy of Iloperidone in the Treatment of Schizophrenia
- (2008) Steven G. Potkin et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
- How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
- (2008) S Leucht et al. MOLECULAR PSYCHIATRY
- Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study
- (2008) Daniel E. Casey et al. PSYCHOPHARMACOLOGY
- What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It?
- (2008) A. S. Kemp et al. SCHIZOPHRENIA BULLETIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search